| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,023 |
15,384 |
$616K |
| S9083 |
Global fee urgent care centers |
7,243 |
6,457 |
$398K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,057 |
4,051 |
$278K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,343 |
3,335 |
$190K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,790 |
2,621 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,563 |
2,474 |
$50K |
| 99215 |
Prolong outpt/office vis |
482 |
465 |
$27K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
327 |
325 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
133 |
132 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,821 |
1,780 |
$3K |
| 81003 |
|
1,809 |
1,738 |
$3K |
| 99000 |
|
1,008 |
984 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
245 |
242 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
239 |
238 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
174 |
84 |
$946.98 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
22 |
22 |
$790.38 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
118 |
118 |
$204.48 |
| 94760 |
|
29 |
28 |
$149.31 |
| 94664 |
|
12 |
12 |
$78.15 |
| 99441 |
|
130 |
123 |
$26.10 |
| 99442 |
|
40 |
40 |
$20.89 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
14 |
$3.88 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$1.44 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
96 |
94 |
$0.16 |
| H0001 |
Alcohol and/or drug assessment |
500 |
485 |
$0.00 |
| G9459 |
Currently a tobacco non-user |
330 |
327 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
65 |
64 |
$0.00 |
| 2010F |
|
34 |
33 |
$0.00 |
| 99443 |
|
42 |
42 |
$0.00 |
| 1033F |
|
288 |
283 |
$0.00 |
| 99401 |
|
86 |
85 |
$0.00 |